nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PTGS1—kidney cancer	0.318	1	CbGaD
Pioglitazone—SLCO1B3—Paclitaxel—kidney cancer	0.0683	0.154	CbGbCtD
Pioglitazone—SLCO1B1—Pazopanib—kidney cancer	0.0609	0.137	CbGbCtD
Pioglitazone—CYP2D6—Temsirolimus—kidney cancer	0.0313	0.0706	CbGbCtD
Pioglitazone—CYP3A4—Everolimus—kidney cancer	0.0295	0.0664	CbGbCtD
Pioglitazone—CYP2C8—Pazopanib—kidney cancer	0.0258	0.0581	CbGbCtD
Pioglitazone—CYP3A4—Temsirolimus—kidney cancer	0.0199	0.0449	CbGbCtD
Pioglitazone—CYP2C9—Capecitabine—kidney cancer	0.0188	0.0423	CbGbCtD
Pioglitazone—CYP2C8—Erlotinib—kidney cancer	0.0184	0.0415	CbGbCtD
Pioglitazone—CYP2C8—Paclitaxel—kidney cancer	0.0168	0.038	CbGbCtD
Pioglitazone—CYP2D6—Pazopanib—kidney cancer	0.0164	0.0371	CbGbCtD
Pioglitazone—CYP2C8—Sorafenib—kidney cancer	0.015	0.0337	CbGbCtD
Pioglitazone—CYP2C19—Sorafenib—kidney cancer	0.0125	0.0283	CbGbCtD
Pioglitazone—CYP2C9—Paclitaxel—kidney cancer	0.0117	0.0265	CbGbCtD
Pioglitazone—CYP2D6—Erlotinib—kidney cancer	0.0117	0.0265	CbGbCtD
Pioglitazone—CYP3A4—Pazopanib—kidney cancer	0.0105	0.0236	CbGbCtD
Pioglitazone—CYP2C9—Sorafenib—kidney cancer	0.0104	0.0235	CbGbCtD
Pioglitazone—CYP2D6—Sorafenib—kidney cancer	0.00954	0.0215	CbGbCtD
Pioglitazone—CYP2D6—Vinblastine—kidney cancer	0.00942	0.0212	CbGbCtD
Pioglitazone—CYP3A4—Erlotinib—kidney cancer	0.00746	0.0168	CbGbCtD
Pioglitazone—CYP3A4—Paclitaxel—kidney cancer	0.00683	0.0154	CbGbCtD
Pioglitazone—CYP3A4—Sorafenib—kidney cancer	0.00607	0.0137	CbGbCtD
Pioglitazone—CYP3A4—Vinblastine—kidney cancer	0.00599	0.0135	CbGbCtD
Pioglitazone—CYP3A4—Vincristine—kidney cancer	0.00589	0.0133	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—kidney cancer	0.00579	0.013	CbGbCtD
Pioglitazone—CYP3A4—Sunitinib—kidney cancer	0.00491	0.0111	CbGbCtD
Pioglitazone—PPARG—nephron—kidney cancer	0.00396	0.221	CbGeAlD
Pioglitazone—CYP3A4—Doxorubicin—kidney cancer	0.00368	0.0083	CbGbCtD
Pioglitazone—CYP2C19—urine—kidney cancer	0.0024	0.134	CbGeAlD
Pioglitazone—PPARG—Everolimus—Temsirolimus—kidney cancer	0.00235	1	CbGdCrCtD
Pioglitazone—CYP2C9—urine—kidney cancer	0.00186	0.104	CbGeAlD
Pioglitazone—CYP3A4—urine—kidney cancer	0.00142	0.0793	CbGeAlD
Pioglitazone—CYP2D6—urine—kidney cancer	0.0014	0.078	CbGeAlD
Pioglitazone—Rosiglitazone—PTGS1—kidney cancer	0.0011	1	CrCbGaD
Pioglitazone—SLCO1B1—renal system—kidney cancer	0.000901	0.0504	CbGeAlD
Pioglitazone—SLCO1B1—kidney—kidney cancer	0.000871	0.0487	CbGeAlD
Pioglitazone—PPARG—renal system—kidney cancer	0.000777	0.0435	CbGeAlD
Pioglitazone—PPARG—kidney—kidney cancer	0.000751	0.042	CbGeAlD
Pioglitazone—CYP2C8—renal system—kidney cancer	0.000512	0.0286	CbGeAlD
Pioglitazone—CYP2C8—kidney—kidney cancer	0.000495	0.0277	CbGeAlD
Pioglitazone—PTGS1—renal system—kidney cancer	0.000415	0.0232	CbGeAlD
Pioglitazone—PTGS1—kidney—kidney cancer	0.000402	0.0225	CbGeAlD
Pioglitazone—PTGS1—cardiac atrium—kidney cancer	0.000372	0.0208	CbGeAlD
Pioglitazone—CYP3A4—renal system—kidney cancer	0.000347	0.0194	CbGeAlD
Pioglitazone—CYP2D6—renal system—kidney cancer	0.000341	0.0191	CbGeAlD
Pioglitazone—CYP3A4—kidney—kidney cancer	0.000335	0.0188	CbGeAlD
Pioglitazone—CYP2D6—kidney—kidney cancer	0.00033	0.0185	CbGeAlD
Pioglitazone—Pharyngitis—Paclitaxel—kidney cancer	0.000156	0.000873	CcSEcCtD
Pioglitazone—Urinary tract disorder—Paclitaxel—kidney cancer	0.000155	0.000868	CcSEcCtD
Pioglitazone—Bronchitis—Capecitabine—kidney cancer	0.000155	0.000867	CcSEcCtD
Pioglitazone—Oedema peripheral—Paclitaxel—kidney cancer	0.000155	0.000866	CcSEcCtD
Pioglitazone—Vertigo—Vincristine—kidney cancer	0.000154	0.000866	CcSEcCtD
Pioglitazone—Connective tissue disorder—Paclitaxel—kidney cancer	0.000154	0.000864	CcSEcCtD
Pioglitazone—Urethral disorder—Paclitaxel—kidney cancer	0.000154	0.000862	CcSEcCtD
Pioglitazone—Dyspnoea—Sorafenib—kidney cancer	0.000154	0.000862	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Doxorubicin—kidney cancer	0.000152	0.000851	CcSEcCtD
Pioglitazone—Ill-defined disorder—Gemcitabine—kidney cancer	0.000151	0.000848	CcSEcCtD
Pioglitazone—Visual impairment—Paclitaxel—kidney cancer	0.000151	0.000847	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000151	0.000847	CcSEcCtD
Pioglitazone—Anaemia—Gemcitabine—kidney cancer	0.000151	0.000845	CcSEcCtD
Pioglitazone—Insomnia—Sunitinib—kidney cancer	0.00015	0.000841	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000149	0.000838	CcSEcCtD
Pioglitazone—Neoplasm—Doxorubicin—kidney cancer	0.000149	0.000837	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000149	0.000834	CcSEcCtD
Pioglitazone—Fatigue—Sorafenib—kidney cancer	0.000149	0.000833	CcSEcCtD
Pioglitazone—Hypertension—Vincristine—kidney cancer	0.000148	0.000832	CcSEcCtD
Pioglitazone—Dyspnoea—Sunitinib—kidney cancer	0.000148	0.000829	CcSEcCtD
Pioglitazone—Malaise—Gemcitabine—kidney cancer	0.000147	0.000824	CcSEcCtD
Pioglitazone—Pulmonary oedema—Doxorubicin—kidney cancer	0.000147	0.000824	CcSEcCtD
Pioglitazone—Hypersensitivity—Vinblastine—kidney cancer	0.000147	0.000823	CcSEcCtD
Pioglitazone—Eye disorder—Paclitaxel—kidney cancer	0.000147	0.000822	CcSEcCtD
Pioglitazone—Myalgia—Vincristine—kidney cancer	0.000146	0.00082	CcSEcCtD
Pioglitazone—Weight increased—Capecitabine—kidney cancer	0.000146	0.00082	CcSEcCtD
Pioglitazone—Hypersensitivity—Everolimus—kidney cancer	0.000146	0.00082	CcSEcCtD
Pioglitazone—Cardiac disorder—Paclitaxel—kidney cancer	0.000146	0.000816	CcSEcCtD
Pioglitazone—Weight decreased—Capecitabine—kidney cancer	0.000146	0.000816	CcSEcCtD
Pioglitazone—Hyperglycaemia—Capecitabine—kidney cancer	0.000145	0.000813	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—kidney cancer	0.000144	0.000808	CcSEcCtD
Pioglitazone—Infestation—Capecitabine—kidney cancer	0.000143	0.000804	CcSEcCtD
Pioglitazone—Infestation NOS—Capecitabine—kidney cancer	0.000143	0.000804	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000143	0.000803	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000143	0.000802	CcSEcCtD
Pioglitazone—Asthenia—Vinblastine—kidney cancer	0.000143	0.000802	CcSEcCtD
Pioglitazone—Fatigue—Sunitinib—kidney cancer	0.000143	0.000802	CcSEcCtD
Pioglitazone—Asthenia—Everolimus—kidney cancer	0.000143	0.000799	CcSEcCtD
Pioglitazone—Immune system disorder—Paclitaxel—kidney cancer	0.000142	0.000794	CcSEcCtD
Pioglitazone—Mediastinal disorder—Paclitaxel—kidney cancer	0.000141	0.000792	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Capecitabine—kidney cancer	0.000141	0.000792	CcSEcCtD
Pioglitazone—Hypertension—Gemcitabine—kidney cancer	0.000141	0.000789	CcSEcCtD
Pioglitazone—Myocardial infarction—Capecitabine—kidney cancer	0.000141	0.000788	CcSEcCtD
Pioglitazone—Oedema—Vincristine—kidney cancer	0.00014	0.000786	CcSEcCtD
Pioglitazone—Anaphylactic shock—Vincristine—kidney cancer	0.00014	0.000786	CcSEcCtD
Pioglitazone—Infection—Vincristine—kidney cancer	0.000139	0.000781	CcSEcCtD
Pioglitazone—Urinary tract infection—Capecitabine—kidney cancer	0.000139	0.000781	CcSEcCtD
Pioglitazone—Myalgia—Gemcitabine—kidney cancer	0.000139	0.000778	CcSEcCtD
Pioglitazone—Chest pain—Gemcitabine—kidney cancer	0.000139	0.000778	CcSEcCtD
Pioglitazone—Arthralgia—Gemcitabine—kidney cancer	0.000139	0.000778	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—kidney cancer	0.000138	0.000773	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000138	0.000773	CcSEcCtD
Pioglitazone—Nervous system disorder—Vincristine—kidney cancer	0.000138	0.000771	CcSEcCtD
Pioglitazone—Asthenia—Erlotinib—kidney cancer	0.000137	0.000771	CcSEcCtD
Pioglitazone—Discomfort—Gemcitabine—kidney cancer	0.000137	0.000769	CcSEcCtD
Pioglitazone—Urticaria—Sorafenib—kidney cancer	0.000137	0.000768	CcSEcCtD
Pioglitazone—Haematuria—Capecitabine—kidney cancer	0.000137	0.000766	CcSEcCtD
Pioglitazone—Malnutrition—Paclitaxel—kidney cancer	0.000137	0.000765	CcSEcCtD
Pioglitazone—Diarrhoea—Vinblastine—kidney cancer	0.000136	0.000765	CcSEcCtD
Pioglitazone—Diarrhoea—Everolimus—kidney cancer	0.000136	0.000762	CcSEcCtD
Pioglitazone—Hyperhidrosis—Vincristine—kidney cancer	0.000136	0.00076	CcSEcCtD
Pioglitazone—Fatigue—Dactinomycin—kidney cancer	0.000135	0.000759	CcSEcCtD
Pioglitazone—Flatulence—Paclitaxel—kidney cancer	0.000135	0.000754	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—kidney cancer	0.000133	0.000748	CcSEcCtD
Pioglitazone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000133	0.000746	CcSEcCtD
Pioglitazone—Oedema—Gemcitabine—kidney cancer	0.000133	0.000746	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000132	0.000741	CcSEcCtD
Pioglitazone—Infection—Gemcitabine—kidney cancer	0.000132	0.000741	CcSEcCtD
Pioglitazone—Back pain—Paclitaxel—kidney cancer	0.000132	0.00074	CcSEcCtD
Pioglitazone—Dizziness—Vinblastine—kidney cancer	0.000132	0.000739	CcSEcCtD
Pioglitazone—Dizziness—Everolimus—kidney cancer	0.000131	0.000736	CcSEcCtD
Pioglitazone—Muscle spasms—Paclitaxel—kidney cancer	0.000131	0.000736	CcSEcCtD
Pioglitazone—Diarrhoea—Erlotinib—kidney cancer	0.000131	0.000735	CcSEcCtD
Pioglitazone—Nervous system disorder—Gemcitabine—kidney cancer	0.000131	0.000732	CcSEcCtD
Pioglitazone—Feeling abnormal—Dactinomycin—kidney cancer	0.000129	0.000725	CcSEcCtD
Pioglitazone—Skin disorder—Gemcitabine—kidney cancer	0.000129	0.000725	CcSEcCtD
Pioglitazone—Hepatitis—Capecitabine—kidney cancer	0.000129	0.000722	CcSEcCtD
Pioglitazone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000129	0.000721	CcSEcCtD
Pioglitazone—Hypoaesthesia—Capecitabine—kidney cancer	0.000128	0.000718	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000128	0.000717	CcSEcCtD
Pioglitazone—Pharyngitis—Capecitabine—kidney cancer	0.000128	0.000716	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—kidney cancer	0.000128	0.000716	CcSEcCtD
Pioglitazone—Urinary tract disorder—Capecitabine—kidney cancer	0.000127	0.000713	CcSEcCtD
Pioglitazone—Hypersensitivity—Sorafenib—kidney cancer	0.000127	0.000712	CcSEcCtD
Pioglitazone—Insomnia—Vincristine—kidney cancer	0.000127	0.000711	CcSEcCtD
Pioglitazone—Oedema peripheral—Capecitabine—kidney cancer	0.000127	0.000711	CcSEcCtD
Pioglitazone—Dizziness—Erlotinib—kidney cancer	0.000127	0.00071	CcSEcCtD
Pioglitazone—Ill-defined disorder—Paclitaxel—kidney cancer	0.000127	0.00071	CcSEcCtD
Pioglitazone—Connective tissue disorder—Capecitabine—kidney cancer	0.000127	0.000709	CcSEcCtD
Pioglitazone—Anaemia—Paclitaxel—kidney cancer	0.000126	0.000707	CcSEcCtD
Pioglitazone—Urethral disorder—Capecitabine—kidney cancer	0.000126	0.000707	CcSEcCtD
Pioglitazone—Headache—Vinblastine—kidney cancer	0.000125	0.0007	CcSEcCtD
Pioglitazone—Angioedema—Paclitaxel—kidney cancer	0.000125	0.000699	CcSEcCtD
Pioglitazone—Headache—Everolimus—kidney cancer	0.000124	0.000697	CcSEcCtD
Pioglitazone—Visual impairment—Capecitabine—kidney cancer	0.000124	0.000695	CcSEcCtD
Pioglitazone—Asthenia—Sorafenib—kidney cancer	0.000124	0.000693	CcSEcCtD
Pioglitazone—Malaise—Paclitaxel—kidney cancer	0.000123	0.00069	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—kidney cancer	0.000123	0.000689	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—kidney cancer	0.000123	0.000689	CcSEcCtD
Pioglitazone—Vertigo—Paclitaxel—kidney cancer	0.000123	0.000688	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000122	0.000686	CcSEcCtD
Pioglitazone—Hypersensitivity—Sunitinib—kidney cancer	0.000122	0.000685	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000121	0.00068	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000121	0.000679	CcSEcCtD
Pioglitazone—Fatigue—Vincristine—kidney cancer	0.000121	0.000678	CcSEcCtD
Pioglitazone—Insomnia—Gemcitabine—kidney cancer	0.00012	0.000675	CcSEcCtD
Pioglitazone—Eye disorder—Capecitabine—kidney cancer	0.00012	0.000674	CcSEcCtD
Pioglitazone—Headache—Erlotinib—kidney cancer	0.00012	0.000673	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—kidney cancer	0.00012	0.000672	CcSEcCtD
Pioglitazone—Cardiac disorder—Capecitabine—kidney cancer	0.000119	0.00067	CcSEcCtD
Pioglitazone—Asthenia—Sunitinib—kidney cancer	0.000119	0.000667	CcSEcCtD
Pioglitazone—Dyspnoea—Gemcitabine—kidney cancer	0.000119	0.000665	CcSEcCtD
Pioglitazone—Diarrhoea—Sorafenib—kidney cancer	0.000118	0.000661	CcSEcCtD
Pioglitazone—Hypertension—Paclitaxel—kidney cancer	0.000118	0.000661	CcSEcCtD
Pioglitazone—Immune system disorder—Capecitabine—kidney cancer	0.000116	0.000652	CcSEcCtD
Pioglitazone—Chest pain—Paclitaxel—kidney cancer	0.000116	0.000652	CcSEcCtD
Pioglitazone—Arthralgia—Paclitaxel—kidney cancer	0.000116	0.000652	CcSEcCtD
Pioglitazone—Myalgia—Paclitaxel—kidney cancer	0.000116	0.000652	CcSEcCtD
Pioglitazone—Mediastinal disorder—Capecitabine—kidney cancer	0.000116	0.00065	CcSEcCtD
Pioglitazone—Hypersensitivity—Dactinomycin—kidney cancer	0.000116	0.000649	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000115	0.000647	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000115	0.000644	CcSEcCtD
Pioglitazone—Discomfort—Paclitaxel—kidney cancer	0.000115	0.000644	CcSEcCtD
Pioglitazone—Fatigue—Gemcitabine—kidney cancer	0.000115	0.000643	CcSEcCtD
Pioglitazone—Dizziness—Sorafenib—kidney cancer	0.000114	0.000639	CcSEcCtD
Pioglitazone—Diarrhoea—Sunitinib—kidney cancer	0.000114	0.000636	CcSEcCtD
Pioglitazone—Asthenia—Dactinomycin—kidney cancer	0.000113	0.000632	CcSEcCtD
Pioglitazone—Malnutrition—Capecitabine—kidney cancer	0.000112	0.000628	CcSEcCtD
Pioglitazone—Oedema—Paclitaxel—kidney cancer	0.000111	0.000625	CcSEcCtD
Pioglitazone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000111	0.000625	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—kidney cancer	0.000111	0.000621	CcSEcCtD
Pioglitazone—Infection—Paclitaxel—kidney cancer	0.000111	0.000621	CcSEcCtD
Pioglitazone—Flatulence—Capecitabine—kidney cancer	0.00011	0.000619	CcSEcCtD
Pioglitazone—Dizziness—Sunitinib—kidney cancer	0.00011	0.000615	CcSEcCtD
Pioglitazone—Feeling abnormal—Gemcitabine—kidney cancer	0.00011	0.000615	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—kidney cancer	0.00011	0.000614	CcSEcCtD
Pioglitazone—Nervous system disorder—Paclitaxel—kidney cancer	0.000109	0.000613	CcSEcCtD
Pioglitazone—Back pain—Capecitabine—kidney cancer	0.000108	0.000608	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—kidney cancer	0.000108	0.000608	CcSEcCtD
Pioglitazone—Skin disorder—Paclitaxel—kidney cancer	0.000108	0.000607	CcSEcCtD
Pioglitazone—Headache—Sorafenib—kidney cancer	0.000108	0.000605	CcSEcCtD
Pioglitazone—Muscle spasms—Capecitabine—kidney cancer	0.000108	0.000604	CcSEcCtD
Pioglitazone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000108	0.000604	CcSEcCtD
Pioglitazone—Diarrhoea—Dactinomycin—kidney cancer	0.000107	0.000602	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000106	0.000593	CcSEcCtD
Pioglitazone—Ill-defined disorder—Capecitabine—kidney cancer	0.000104	0.000583	CcSEcCtD
Pioglitazone—Headache—Sunitinib—kidney cancer	0.000104	0.000583	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—kidney cancer	0.000104	0.000581	CcSEcCtD
Pioglitazone—Anaemia—Capecitabine—kidney cancer	0.000104	0.000581	CcSEcCtD
Pioglitazone—Hypersensitivity—Vincristine—kidney cancer	0.000103	0.000579	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000102	0.000569	CcSEcCtD
Pioglitazone—Malaise—Capecitabine—kidney cancer	0.000101	0.000566	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—kidney cancer	0.000101	0.000566	CcSEcCtD
Pioglitazone—Insomnia—Paclitaxel—kidney cancer	0.000101	0.000565	CcSEcCtD
Pioglitazone—Vertigo—Capecitabine—kidney cancer	0.000101	0.000564	CcSEcCtD
Pioglitazone—Asthenia—Vincristine—kidney cancer	0.000101	0.000564	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—kidney cancer	9.97e-05	0.000559	CcSEcCtD
Pioglitazone—Dyspnoea—Paclitaxel—kidney cancer	9.94e-05	0.000557	CcSEcCtD
Pioglitazone—Hypertension—Capecitabine—kidney cancer	9.68e-05	0.000542	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.64e-05	0.00054	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Paclitaxel—kidney cancer	9.62e-05	0.000539	CcSEcCtD
Pioglitazone—Fatigue—Paclitaxel—kidney cancer	9.61e-05	0.000539	CcSEcCtD
Pioglitazone—Diarrhoea—Vincristine—kidney cancer	9.6e-05	0.000538	CcSEcCtD
Pioglitazone—Asthenia—Gemcitabine—kidney cancer	9.55e-05	0.000535	CcSEcCtD
Pioglitazone—Arthralgia—Capecitabine—kidney cancer	9.54e-05	0.000535	CcSEcCtD
Pioglitazone—Myalgia—Capecitabine—kidney cancer	9.54e-05	0.000535	CcSEcCtD
Pioglitazone—Chest pain—Capecitabine—kidney cancer	9.54e-05	0.000535	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.47e-05	0.000531	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—kidney cancer	9.43e-05	0.000529	CcSEcCtD
Pioglitazone—Discomfort—Capecitabine—kidney cancer	9.43e-05	0.000528	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—kidney cancer	9.38e-05	0.000526	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—kidney cancer	9.35e-05	0.000524	CcSEcCtD
Pioglitazone—Dizziness—Vincristine—kidney cancer	9.28e-05	0.00052	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—kidney cancer	9.24e-05	0.000518	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—kidney cancer	9.24e-05	0.000518	CcSEcCtD
Pioglitazone—Feeling abnormal—Paclitaxel—kidney cancer	9.18e-05	0.000515	CcSEcCtD
Pioglitazone—Oedema—Capecitabine—kidney cancer	9.15e-05	0.000513	CcSEcCtD
Pioglitazone—Diarrhoea—Gemcitabine—kidney cancer	9.11e-05	0.00051	CcSEcCtD
Pioglitazone—Infection—Capecitabine—kidney cancer	9.09e-05	0.000509	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—kidney cancer	8.99e-05	0.000504	CcSEcCtD
Pioglitazone—Nervous system disorder—Capecitabine—kidney cancer	8.97e-05	0.000503	CcSEcCtD
Pioglitazone—Skin disorder—Capecitabine—kidney cancer	8.88e-05	0.000498	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—kidney cancer	8.86e-05	0.000497	CcSEcCtD
Pioglitazone—Urticaria—Paclitaxel—kidney cancer	8.85e-05	0.000496	CcSEcCtD
Pioglitazone—Hyperhidrosis—Capecitabine—kidney cancer	8.84e-05	0.000496	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—kidney cancer	8.81e-05	0.000494	CcSEcCtD
Pioglitazone—Headache—Vincristine—kidney cancer	8.79e-05	0.000493	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—kidney cancer	8.67e-05	0.000486	CcSEcCtD
Pioglitazone—Headache—Gemcitabine—kidney cancer	8.34e-05	0.000467	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.33e-05	0.000467	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—kidney cancer	8.3e-05	0.000465	CcSEcCtD
Pioglitazone—Insomnia—Capecitabine—kidney cancer	8.27e-05	0.000464	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—kidney cancer	8.26e-05	0.000463	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—kidney cancer	8.24e-05	0.000462	CcSEcCtD
Pioglitazone—Hypersensitivity—Paclitaxel—kidney cancer	8.21e-05	0.00046	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—kidney cancer	8.19e-05	0.000459	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—kidney cancer	8.17e-05	0.000458	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—kidney cancer	8.15e-05	0.000457	CcSEcCtD
Pioglitazone—Dyspnoea—Capecitabine—kidney cancer	8.15e-05	0.000457	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—kidney cancer	8.13e-05	0.000456	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—kidney cancer	8e-05	0.000448	CcSEcCtD
Pioglitazone—Asthenia—Paclitaxel—kidney cancer	8e-05	0.000448	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Capecitabine—kidney cancer	7.9e-05	0.000443	CcSEcCtD
Pioglitazone—Fatigue—Capecitabine—kidney cancer	7.89e-05	0.000442	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—kidney cancer	7.75e-05	0.000435	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—kidney cancer	7.7e-05	0.000432	CcSEcCtD
Pioglitazone—Diarrhoea—Paclitaxel—kidney cancer	7.63e-05	0.000427	CcSEcCtD
Pioglitazone—Feeling abnormal—Capecitabine—kidney cancer	7.54e-05	0.000422	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—kidney cancer	7.5e-05	0.00042	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—kidney cancer	7.48e-05	0.000419	CcSEcCtD
Pioglitazone—Dizziness—Paclitaxel—kidney cancer	7.37e-05	0.000413	CcSEcCtD
Pioglitazone—Urticaria—Capecitabine—kidney cancer	7.27e-05	0.000407	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—kidney cancer	7.22e-05	0.000405	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—kidney cancer	7.12e-05	0.000399	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—kidney cancer	6.99e-05	0.000392	CcSEcCtD
Pioglitazone—Headache—Paclitaxel—kidney cancer	6.98e-05	0.000391	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—kidney cancer	6.94e-05	0.000389	CcSEcCtD
Pioglitazone—Hypersensitivity—Capecitabine—kidney cancer	6.74e-05	0.000378	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—kidney cancer	6.7e-05	0.000376	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—kidney cancer	6.68e-05	0.000374	CcSEcCtD
Pioglitazone—Asthenia—Capecitabine—kidney cancer	6.56e-05	0.000368	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—kidney cancer	6.51e-05	0.000365	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—kidney cancer	6.49e-05	0.000364	CcSEcCtD
Pioglitazone—Diarrhoea—Capecitabine—kidney cancer	6.26e-05	0.000351	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—kidney cancer	6.24e-05	0.00035	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—kidney cancer	6.15e-05	0.000345	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—kidney cancer	6.15e-05	0.000345	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—kidney cancer	6.15e-05	0.000345	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.11e-05	0.000342	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—kidney cancer	6.08e-05	0.000341	CcSEcCtD
Pioglitazone—Dizziness—Capecitabine—kidney cancer	6.05e-05	0.000339	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—kidney cancer	5.9e-05	0.00033	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—kidney cancer	5.9e-05	0.00033	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—kidney cancer	5.86e-05	0.000328	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—kidney cancer	5.78e-05	0.000324	CcSEcCtD
Pioglitazone—Headache—Capecitabine—kidney cancer	5.73e-05	0.000321	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—kidney cancer	5.73e-05	0.000321	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—kidney cancer	5.7e-05	0.000319	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.37e-05	0.000301	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—kidney cancer	5.33e-05	0.000299	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—kidney cancer	5.26e-05	0.000295	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.09e-05	0.000285	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—kidney cancer	5.08e-05	0.000285	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—kidney cancer	4.86e-05	0.000272	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—kidney cancer	4.68e-05	0.000263	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—kidney cancer	4.34e-05	0.000243	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—kidney cancer	4.23e-05	0.000237	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—kidney cancer	4.03e-05	0.000226	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—kidney cancer	3.9e-05	0.000219	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—kidney cancer	3.69e-05	0.000207	CcSEcCtD
Pioglitazone—PPARG—Metabolism—SLC5A5—kidney cancer	1.69e-05	0.000438	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.69e-05	0.000437	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.69e-05	0.000437	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPC3—kidney cancer	1.68e-05	0.000434	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.67e-05	0.000433	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.66e-05	0.000431	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—SLC2A1—kidney cancer	1.64e-05	0.000423	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CA2—kidney cancer	1.63e-05	0.000422	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.63e-05	0.000421	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CRABP1—kidney cancer	1.63e-05	0.000421	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.62e-05	0.00042	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GSTP1—kidney cancer	1.6e-05	0.000414	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—FH—kidney cancer	1.59e-05	0.000412	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APRT—kidney cancer	1.59e-05	0.000412	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—CTNNB1—kidney cancer	1.59e-05	0.000412	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALAD—kidney cancer	1.59e-05	0.000411	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.59e-05	0.000411	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.57e-05	0.000407	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPAT—kidney cancer	1.57e-05	0.000407	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.57e-05	0.000406	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPAT—kidney cancer	1.56e-05	0.000404	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.56e-05	0.000404	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.55e-05	0.000402	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.55e-05	0.000401	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ACHE—kidney cancer	1.55e-05	0.000401	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTT1—kidney cancer	1.55e-05	0.000401	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.54e-05	0.000399	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.52e-05	0.000395	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.52e-05	0.000392	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ABCB1—kidney cancer	1.51e-05	0.000392	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ITPR2—kidney cancer	1.51e-05	0.000391	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPC3—kidney cancer	1.5e-05	0.000387	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ACY1—kidney cancer	1.48e-05	0.000384	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GSTM1—kidney cancer	1.47e-05	0.00038	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SCARB1—kidney cancer	1.47e-05	0.00038	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APRT—kidney cancer	1.46e-05	0.000379	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—FH—kidney cancer	1.46e-05	0.000379	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CA2—kidney cancer	1.45e-05	0.000377	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.45e-05	0.000376	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PGK1—kidney cancer	1.45e-05	0.000376	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS1—kidney cancer	1.45e-05	0.000376	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—FH—kidney cancer	1.45e-05	0.000375	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APRT—kidney cancer	1.45e-05	0.000375	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—LDHB—kidney cancer	1.42e-05	0.000369	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PSMD7—kidney cancer	1.42e-05	0.000369	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALAD—kidney cancer	1.42e-05	0.000367	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.42e-05	0.000367	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—VEGFA—kidney cancer	1.4e-05	0.000362	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.39e-05	0.000361	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP1A1—kidney cancer	1.39e-05	0.000361	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.38e-05	0.000358	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.38e-05	0.000358	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTT1—kidney cancer	1.38e-05	0.000357	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ACHE—kidney cancer	1.38e-05	0.000357	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPC3—kidney cancer	1.38e-05	0.000356	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—MYC—kidney cancer	1.37e-05	0.000354	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSTP1—kidney cancer	1.36e-05	0.000353	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPC3—kidney cancer	1.36e-05	0.000353	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.35e-05	0.00035	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—BCHE—kidney cancer	1.35e-05	0.000349	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CA2—kidney cancer	1.34e-05	0.000346	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.33e-05	0.000345	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CA2—kidney cancer	1.33e-05	0.000343	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK3—kidney cancer	1.32e-05	0.000343	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SCARB1—kidney cancer	1.3e-05	0.000338	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALAD—kidney cancer	1.3e-05	0.000338	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.3e-05	0.000336	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PGK1—kidney cancer	1.3e-05	0.000336	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALAD—kidney cancer	1.29e-05	0.000335	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ABCB1—kidney cancer	1.29e-05	0.000334	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.29e-05	0.000333	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.27e-05	0.00033	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—LDHB—kidney cancer	1.27e-05	0.000329	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PSMD7—kidney cancer	1.27e-05	0.000328	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PDHB—kidney cancer	1.26e-05	0.000327	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.26e-05	0.000327	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK1—kidney cancer	1.26e-05	0.000326	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.26e-05	0.000326	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSTM1—kidney cancer	1.25e-05	0.000325	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.25e-05	0.000323	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.24e-05	0.000322	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CA9—kidney cancer	1.24e-05	0.00032	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.23e-05	0.000319	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.23e-05	0.000318	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.21e-05	0.000313	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—BCHE—kidney cancer	1.2e-05	0.000311	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.19e-05	0.000309	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PGK1—kidney cancer	1.19e-05	0.000309	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—KRAS—kidney cancer	1.19e-05	0.000308	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP1A1—kidney cancer	1.19e-05	0.000308	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.19e-05	0.000307	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SLC5A5—kidney cancer	1.19e-05	0.000307	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PGK1—kidney cancer	1.18e-05	0.000306	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.18e-05	0.000306	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LDHB—kidney cancer	1.17e-05	0.000303	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LDHB—kidney cancer	1.16e-05	0.0003	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SLC2A1—kidney cancer	1.15e-05	0.000297	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.14e-05	0.000296	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.11e-05	0.000288	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CA9—kidney cancer	1.1e-05	0.000285	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.09e-05	0.000282	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.08e-05	0.000279	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.07e-05	0.000278	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CRABP1—kidney cancer	1.05e-05	0.000272	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—POMC—kidney cancer	1.04e-05	0.000269	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.03e-05	0.000266	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPAT—kidney cancer	1.03e-05	0.000266	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.02e-05	0.000263	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CA9—kidney cancer	1.01e-05	0.000263	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CA9—kidney cancer	1.01e-05	0.00026	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTM1—kidney cancer	9.87e-06	0.000256	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.83e-06	0.000254	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ITPR2—kidney cancer	9.76e-06	0.000253	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.76e-06	0.000253	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.69e-06	0.000251	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APRT—kidney cancer	9.57e-06	0.000248	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—FH—kidney cancer	9.57e-06	0.000248	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTP1—kidney cancer	9.55e-06	0.000247	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CRABP1—kidney cancer	9.37e-06	0.000243	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP1A1—kidney cancer	9.36e-06	0.000242	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ABCB1—kidney cancer	9.04e-06	0.000234	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9e-06	0.000233	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPC3—kidney cancer	8.99e-06	0.000233	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTT1—kidney cancer	8.9e-06	0.000231	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ACHE—kidney cancer	8.9e-06	0.000231	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—POMC—kidney cancer	8.86e-06	0.000229	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTM1—kidney cancer	8.78e-06	0.000227	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CA2—kidney cancer	8.75e-06	0.000226	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ITPR2—kidney cancer	8.72e-06	0.000226	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CRABP1—kidney cancer	8.62e-06	0.000223	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CRABP1—kidney cancer	8.55e-06	0.000221	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALAD—kidney cancer	8.53e-06	0.000221	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SCARB1—kidney cancer	8.43e-06	0.000218	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS1—kidney cancer	8.34e-06	0.000216	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1A1—kidney cancer	8.32e-06	0.000215	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.32e-06	0.000215	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—kidney cancer	8.28e-06	0.000214	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PSMD7—kidney cancer	8.18e-06	0.000212	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.13e-06	0.000211	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.03e-06	0.000208	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ITPR2—kidney cancer	8.02e-06	0.000208	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTT1—kidney cancer	7.95e-06	0.000206	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ACHE—kidney cancer	7.95e-06	0.000206	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ITPR2—kidney cancer	7.95e-06	0.000206	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PGK1—kidney cancer	7.8e-06	0.000202	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.8e-06	0.000202	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—BCHE—kidney cancer	7.76e-06	0.000201	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.69e-06	0.000199	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC5A5—kidney cancer	7.66e-06	0.000198	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LDHB—kidney cancer	7.65e-06	0.000198	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SCARB1—kidney cancer	7.52e-06	0.000195	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS1—kidney cancer	7.45e-06	0.000193	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.4e-06	0.000192	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.33e-06	0.00019	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ACHE—kidney cancer	7.31e-06	0.000189	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTT1—kidney cancer	7.31e-06	0.000189	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSMD7—kidney cancer	7.3e-06	0.000189	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ACHE—kidney cancer	7.25e-06	0.000188	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTT1—kidney cancer	7.25e-06	0.000188	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—kidney cancer	7.22e-06	0.000187	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.18e-06	0.000186	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—kidney cancer	7.07e-06	0.000183	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—POMC—kidney cancer	6.98e-06	0.000181	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—BCHE—kidney cancer	6.92e-06	0.000179	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SCARB1—kidney cancer	6.92e-06	0.000179	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SCARB1—kidney cancer	6.86e-06	0.000178	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS1—kidney cancer	6.85e-06	0.000177	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC5A5—kidney cancer	6.84e-06	0.000177	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.84e-06	0.000177	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS1—kidney cancer	6.79e-06	0.000176	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAPK3—kidney cancer	6.77e-06	0.000175	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSMD7—kidney cancer	6.72e-06	0.000174	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSMD7—kidney cancer	6.66e-06	0.000172	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CA9—kidney cancer	6.63e-06	0.000172	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC2A1—kidney cancer	6.61e-06	0.000171	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—kidney cancer	6.59e-06	0.000171	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.41e-06	0.000166	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—BCHE—kidney cancer	6.37e-06	0.000165	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—BCHE—kidney cancer	6.31e-06	0.000163	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.29e-06	0.000163	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.26e-06	0.000162	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.24e-06	0.000161	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—POMC—kidney cancer	6.21e-06	0.000161	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—kidney cancer	6.17e-06	0.00016	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—kidney cancer	6.16e-06	0.00016	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.08e-06	0.000157	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.02e-06	0.000156	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.84e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCB1—kidney cancer	5.84e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—kidney cancer	5.67e-06	0.000147	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CRABP1—kidney cancer	5.64e-06	0.000146	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.59e-06	0.000145	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—kidney cancer	5.56e-06	0.000144	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—kidney cancer	5.51e-06	0.000143	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.38e-06	0.000139	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ITPR2—kidney cancer	5.24e-06	0.000136	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCB1—kidney cancer	5.21e-06	0.000135	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.1e-06	0.000132	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—kidney cancer	5.1e-06	0.000132	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—kidney cancer	5.07e-06	0.000131	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—kidney cancer	5.06e-06	0.000131	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—kidney cancer	5.02e-06	0.00013	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—kidney cancer	4.95e-06	0.000128	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—kidney cancer	4.85e-06	0.000126	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.8e-06	0.000124	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCB1—kidney cancer	4.8e-06	0.000124	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ACHE—kidney cancer	4.78e-06	0.000124	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTT1—kidney cancer	4.78e-06	0.000124	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCB1—kidney cancer	4.75e-06	0.000123	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—kidney cancer	4.66e-06	0.000121	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—kidney cancer	4.62e-06	0.00012	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SCARB1—kidney cancer	4.52e-06	0.000117	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS1—kidney cancer	4.48e-06	0.000116	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.42e-06	0.000114	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.41e-06	0.000114	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSMD7—kidney cancer	4.39e-06	0.000114	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.38e-06	0.000113	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—kidney cancer	4.35e-06	0.000113	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—kidney cancer	4.32e-06	0.000112	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—BCHE—kidney cancer	4.16e-06	0.000108	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.11e-06	0.000106	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—POMC—kidney cancer	4.01e-06	0.000104	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.97e-06	0.000103	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.94e-06	0.000102	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.59e-06	9.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—POMC—kidney cancer	3.58e-06	9.26e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.42e-06	8.86e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—kidney cancer	3.31e-06	8.58e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—POMC—kidney cancer	3.29e-06	8.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—POMC—kidney cancer	3.26e-06	8.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—kidney cancer	3.2e-06	8.28e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCB1—kidney cancer	3.14e-06	8.12e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—kidney cancer	3.05e-06	7.88e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—kidney cancer	3.04e-06	7.88e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.89e-06	7.47e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—kidney cancer	2.85e-06	7.39e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—kidney cancer	2.79e-06	7.22e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—kidney cancer	2.62e-06	6.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—kidney cancer	2.6e-06	6.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—kidney cancer	2.49e-06	6.44e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—kidney cancer	2.29e-06	5.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—kidney cancer	2.27e-06	5.88e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—POMC—kidney cancer	2.15e-06	5.57e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.97e-06	5.09e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.76e-06	4.55e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.72e-06	4.44e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.61e-06	4.18e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.6e-06	4.14e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—kidney cancer	1.5e-06	3.87e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.06e-06	2.73e-05	CbGpPWpGaD
